Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAFK
|
ENSG00000198517.5 | MAF bZIP transcription factor K |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_1572516_1572667 | MAFK | 2241 | 0.231522 | -0.81 | 7.8e-03 | Click! |
chr7_1571729_1572461 | MAFK | 1745 | 0.281846 | -0.65 | 5.6e-02 | Click! |
chr7_1571068_1571647 | MAFK | 1007 | 0.458884 | -0.65 | 5.8e-02 | Click! |
chr7_1583741_1583892 | MAFK | 5472 | 0.155779 | -0.50 | 1.7e-01 | Click! |
chr7_1572790_1572941 | MAFK | 2515 | 0.213964 | -0.48 | 1.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_96878987_96879612 | 1.61 |
ENSG00000222651 |
. |
2809 |
0.21 |
chr3_112358958_112359194 | 1.57 |
CCDC80 |
coiled-coil domain containing 80 |
1040 |
0.62 |
chr2_38295267_38295509 | 1.51 |
RMDN2-AS1 |
RMDN2 antisense RNA 1 |
1204 |
0.45 |
chr9_21688149_21688723 | 1.38 |
ENSG00000244230 |
. |
10877 |
0.24 |
chr14_90126270_90126545 | 1.35 |
ENSG00000252655 |
. |
9160 |
0.16 |
chr12_91720869_91721159 | 1.32 |
DCN |
decorin |
144114 |
0.05 |
chr12_91504103_91504272 | 1.30 |
LUM |
lumican |
1421 |
0.48 |
chr12_78334342_78334902 | 1.30 |
NAV3 |
neuron navigator 3 |
25434 |
0.27 |
chr5_54456050_54456451 | 1.27 |
GPX8 |
glutathione peroxidase 8 (putative) |
252 |
0.86 |
chr10_17274225_17274484 | 1.27 |
VIM |
vimentin |
1746 |
0.26 |
chr9_114061539_114061711 | 1.26 |
OR2K2 |
olfactory receptor, family 2, subfamily K, member 2 |
29088 |
0.21 |
chr21_17567832_17567983 | 1.25 |
ENSG00000201025 |
. |
89182 |
0.1 |
chr16_14279913_14280368 | 1.18 |
MKL2 |
MKL/myocardin-like 2 |
434 |
0.86 |
chr18_53089837_53090372 | 1.17 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr3_100711576_100712203 | 1.15 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
408 |
0.89 |
chr3_87036535_87037613 | 1.14 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr4_77129108_77129259 | 1.14 |
SCARB2 |
scavenger receptor class B, member 2 |
5573 |
0.18 |
chr2_46933523_46933944 | 1.10 |
SOCS5 |
suppressor of cytokine signaling 5 |
7407 |
0.22 |
chr2_33360890_33361153 | 1.08 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
1297 |
0.6 |
chr2_190041307_190041749 | 1.07 |
COL5A2 |
collagen, type V, alpha 2 |
3077 |
0.31 |
chr13_75466427_75466770 | 1.06 |
ENSG00000206812 |
. |
217126 |
0.02 |
chr5_151065179_151065606 | 1.06 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
601 |
0.67 |
chr10_114714851_114715858 | 1.05 |
RP11-57H14.2 |
|
3720 |
0.26 |
chr7_134464463_134465343 | 1.02 |
CALD1 |
caldesmon 1 |
474 |
0.89 |
chr13_36047277_36047487 | 1.02 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
3450 |
0.24 |
chr4_71589225_71589655 | 1.02 |
RUFY3 |
RUN and FYVE domain containing 3 |
1068 |
0.4 |
chr5_3598562_3598819 | 1.01 |
CTD-2012M11.3 |
|
1612 |
0.42 |
chr3_33318777_33319866 | 0.98 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr7_27153769_27154326 | 0.98 |
HOXA-AS2 |
HOXA cluster antisense RNA 2 |
492 |
0.41 |
chr9_33506853_33507187 | 0.96 |
RP11-255A11.2 |
|
7751 |
0.17 |
chr6_146868018_146868556 | 0.96 |
RAB32 |
RAB32, member RAS oncogene family |
3458 |
0.33 |
chr12_59312903_59313092 | 0.95 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
330 |
0.87 |
chr22_46471692_46472277 | 0.94 |
FLJ27365 |
hsa-mir-4763 |
4208 |
0.11 |
chr18_59249002_59249189 | 0.94 |
CDH20 |
cadherin 20, type 2 |
31996 |
0.25 |
chr6_6006212_6006448 | 0.93 |
NRN1 |
neuritin 1 |
870 |
0.69 |
chr12_69928010_69928354 | 0.93 |
FRS2 |
fibroblast growth factor receptor substrate 2 |
3579 |
0.25 |
chr12_960802_961189 | 0.92 |
WNK1 |
WNK lysine deficient protein kinase 1 |
136 |
0.97 |
chr1_103571993_103572213 | 0.92 |
COL11A1 |
collagen, type XI, alpha 1 |
1631 |
0.56 |
chr7_42717172_42717551 | 0.92 |
C7orf25 |
chromosome 7 open reading frame 25 |
234148 |
0.02 |
chr15_49718551_49718707 | 0.92 |
FGF7 |
fibroblast growth factor 7 |
3172 |
0.3 |
chr5_120114458_120114855 | 0.91 |
ENSG00000222609 |
. |
68121 |
0.14 |
chr7_92325122_92325607 | 0.90 |
ENSG00000206763 |
. |
5764 |
0.28 |
chr12_100988036_100988187 | 0.90 |
GAS2L3 |
growth arrest-specific 2 like 3 |
715 |
0.75 |
chr4_114880025_114880231 | 0.90 |
RP11-26P13.2 |
|
15716 |
0.24 |
chr6_79315199_79315473 | 0.90 |
IRAK1BP1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
261853 |
0.02 |
chr15_36623332_36623712 | 0.89 |
C15orf41 |
chromosome 15 open reading frame 41 |
248290 |
0.02 |
chr6_11196915_11197406 | 0.89 |
RP3-510L9.1 |
|
23475 |
0.18 |
chr21_47401799_47402727 | 0.89 |
COL6A1 |
collagen, type VI, alpha 1 |
612 |
0.75 |
chr2_8272476_8272771 | 0.89 |
AC011747.7 |
|
543273 |
0.0 |
chr6_152701966_152702349 | 0.89 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
476 |
0.79 |
chr10_6780355_6780830 | 0.88 |
PRKCQ |
protein kinase C, theta |
158329 |
0.04 |
chr18_53525579_53526226 | 0.88 |
TCF4 |
transcription factor 4 |
193884 |
0.03 |
chr14_53416235_53416562 | 0.88 |
FERMT2 |
fermitin family member 2 |
888 |
0.69 |
chr5_91977319_91977616 | 0.87 |
ENSG00000221810 |
. |
75753 |
0.13 |
chr6_114182367_114182913 | 0.87 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
4099 |
0.23 |
chr16_54408198_54408422 | 0.87 |
IRX3 |
iroquois homeobox 3 |
87635 |
0.09 |
chr1_114862373_114862591 | 0.86 |
TRIM33 |
tripartite motif containing 33 |
143376 |
0.04 |
chr4_125632186_125632438 | 0.86 |
ANKRD50 |
ankyrin repeat domain 50 |
1575 |
0.58 |
chr6_53457738_53458227 | 0.86 |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
23786 |
0.17 |
chr4_88024645_88024935 | 0.85 |
AFF1 |
AF4/FMR2 family, member 1 |
53986 |
0.15 |
chr12_13350846_13351208 | 0.85 |
EMP1 |
epithelial membrane protein 1 |
1307 |
0.55 |
chr18_53088762_53088982 | 0.85 |
TCF4 |
transcription factor 4 |
714 |
0.72 |
chr11_131780761_131781452 | 0.83 |
NTM |
neurotrimin |
209 |
0.95 |
chr3_120215962_120216316 | 0.83 |
FSTL1 |
follistatin-like 1 |
46039 |
0.16 |
chr2_66802213_66802500 | 0.83 |
MEIS1 |
Meis homeobox 1 |
66297 |
0.13 |
chr5_138209985_138210281 | 0.83 |
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
406 |
0.71 |
chr10_102278895_102279852 | 0.82 |
SEC31B |
SEC31 homolog B (S. cerevisiae) |
218 |
0.92 |
chr9_22007341_22007594 | 0.82 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
1485 |
0.34 |
chr22_46477251_46477772 | 0.82 |
FLJ27365 |
hsa-mir-4763 |
1319 |
0.27 |
chr4_124621914_124622114 | 0.81 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
300891 |
0.01 |
chr2_208000481_208000742 | 0.80 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
1750 |
0.36 |
chr10_24755480_24755818 | 0.80 |
KIAA1217 |
KIAA1217 |
189 |
0.96 |
chr1_2005099_2005545 | 0.80 |
PRKCZ |
protein kinase C, zeta |
103 |
0.96 |
chr1_170633420_170634117 | 0.80 |
PRRX1 |
paired related homeobox 1 |
690 |
0.8 |
chr4_175075425_175075781 | 0.80 |
FBXO8 |
F-box protein 8 |
129211 |
0.05 |
chr13_110957949_110958238 | 0.80 |
COL4A2 |
collagen, type IV, alpha 2 |
66 |
0.97 |
chr6_150176715_150177267 | 0.79 |
RP11-350J20.12 |
|
3393 |
0.15 |
chr5_158247594_158247879 | 0.79 |
CTD-2363C16.1 |
|
162278 |
0.04 |
chr3_116007441_116007592 | 0.79 |
LSAMP-AS1 |
LSAMP antisense RNA 1 |
71355 |
0.13 |
chr15_60685776_60685927 | 0.79 |
ANXA2 |
annexin A2 |
2355 |
0.39 |
chr6_155005040_155005564 | 0.79 |
SCAF8 |
SR-related CTD-associated factor 8 |
49157 |
0.17 |
chr6_130687578_130688581 | 0.78 |
TMEM200A |
transmembrane protein 200A |
1200 |
0.43 |
chr10_4285552_4285907 | 0.77 |
ENSG00000207124 |
. |
271415 |
0.02 |
chr9_21556935_21557192 | 0.77 |
MIR31HG |
MIR31 host gene (non-protein coding) |
2605 |
0.26 |
chr4_71587677_71588145 | 0.77 |
RUFY3 |
RUN and FYVE domain containing 3 |
183 |
0.92 |
chr18_49866610_49867033 | 0.76 |
DCC |
deleted in colorectal carcinoma |
279 |
0.96 |
chr18_52985124_52985322 | 0.75 |
TCF4 |
transcription factor 4 |
3994 |
0.34 |
chr18_53068422_53068903 | 0.75 |
TCF4 |
transcription factor 4 |
96 |
0.98 |
chr2_162927183_162927334 | 0.75 |
AC008063.2 |
|
2508 |
0.29 |
chr20_36298429_36298668 | 0.75 |
CTNNBL1 |
catenin, beta like 1 |
23860 |
0.24 |
chr16_69959859_69960167 | 0.75 |
WWP2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1120 |
0.44 |
chr2_165300571_165300784 | 0.75 |
ENSG00000264074 |
. |
20642 |
0.27 |
chr11_88288591_88288966 | 0.74 |
GRM5-AS1 |
GRM5 antisense RNA 1 |
43862 |
0.18 |
chr3_152314332_152314547 | 0.74 |
RP11-362A9.3 |
|
99837 |
0.08 |
chr5_150153790_150154104 | 0.74 |
SMIM3 |
small integral membrane protein 3 |
3561 |
0.18 |
chr1_215179099_215179440 | 0.74 |
KCNK2 |
potassium channel, subfamily K, member 2 |
71 |
0.99 |
chr10_29922441_29923089 | 0.74 |
SVIL |
supervillin |
1136 |
0.54 |
chr7_114055046_114055222 | 0.74 |
FOXP2 |
forkhead box P2 |
21 |
0.98 |
chr8_32558999_32559150 | 0.73 |
NRG1 |
neuregulin 1 |
20197 |
0.29 |
chr20_19991582_19991882 | 0.73 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
6028 |
0.22 |
chr6_85823864_85824548 | 0.73 |
NT5E |
5'-nucleotidase, ecto (CD73) |
335603 |
0.01 |
chr1_178340504_178341006 | 0.73 |
RASAL2 |
RAS protein activator like 2 |
30149 |
0.22 |
chr21_17907841_17908039 | 0.73 |
ENSG00000207638 |
. |
3469 |
0.26 |
chr4_177674197_177674348 | 0.73 |
VEGFC |
vascular endothelial growth factor C |
39609 |
0.2 |
chr13_99629621_99629906 | 0.73 |
DOCK9 |
dedicator of cytokinesis 9 |
481 |
0.85 |
chr6_145349284_145349464 | 0.73 |
UTRN |
utrophin |
228857 |
0.02 |
chr6_27205685_27206711 | 0.73 |
PRSS16 |
protease, serine, 16 (thymus) |
9282 |
0.19 |
chr7_54910233_54910564 | 0.72 |
ENSG00000252054 |
. |
23113 |
0.23 |
chr12_115119392_115119718 | 0.72 |
TBX3 |
T-box 3 |
1840 |
0.39 |
chr7_116167346_116167524 | 0.72 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
1088 |
0.46 |
chr6_136360177_136360429 | 0.72 |
RP13-143G15.3 |
|
25473 |
0.21 |
chr4_148009583_148009791 | 0.72 |
TTC29 |
tetratricopeptide repeat domain 29 |
142653 |
0.05 |
chr6_146755289_146755690 | 0.72 |
ENSG00000222971 |
. |
93933 |
0.09 |
chr21_17497567_17497931 | 0.72 |
ENSG00000252273 |
. |
89920 |
0.1 |
chr12_84274084_84274235 | 0.72 |
ENSG00000221148 |
. |
303068 |
0.01 |
chr2_86225577_86226007 | 0.72 |
POLR1A |
polymerase (RNA) I polypeptide A, 194kDa |
107486 |
0.05 |
chr7_99277131_99277282 | 0.71 |
CYP3A5 |
cytochrome P450, family 3, subfamily A, polypeptide 5 |
410 |
0.8 |
chr1_9262322_9262703 | 0.71 |
H6PD |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
32322 |
0.15 |
chr1_146641573_146641779 | 0.71 |
PRKAB2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
2370 |
0.23 |
chr7_134465455_134465673 | 0.71 |
CALD1 |
caldesmon 1 |
1135 |
0.64 |
chr1_186153285_186153546 | 0.71 |
GS1-174L6.4 |
|
6981 |
0.23 |
chr1_150481112_150481644 | 0.71 |
ECM1 |
extracellular matrix protein 1 |
795 |
0.48 |
chr21_17442999_17443232 | 0.71 |
ENSG00000252273 |
. |
35286 |
0.24 |
chr10_15411519_15412658 | 0.70 |
FAM171A1 |
family with sequence similarity 171, member A1 |
970 |
0.7 |
chr21_17569279_17569619 | 0.70 |
ENSG00000201025 |
. |
87640 |
0.1 |
chr12_58819523_58819907 | 0.70 |
RP11-362K2.2 |
Protein LOC100506869 |
118192 |
0.06 |
chr6_53875762_53875944 | 0.70 |
MLIP |
muscular LMNA-interacting protein |
7861 |
0.2 |
chr13_96295981_96296211 | 0.70 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
579 |
0.79 |
chr2_30496369_30496656 | 0.70 |
LBH |
limb bud and heart development |
41466 |
0.17 |
chr10_65558718_65559094 | 0.70 |
REEP3 |
receptor accessory protein 3 |
277783 |
0.01 |
chr1_158969828_158970040 | 0.70 |
IFI16 |
interferon, gamma-inducible protein 16 |
176 |
0.96 |
chr22_36235496_36235773 | 0.70 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
631 |
0.82 |
chr6_131360061_131360448 | 0.70 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
23272 |
0.26 |
chr5_79542234_79542540 | 0.70 |
ENSG00000239159 |
. |
6979 |
0.19 |
chr12_91504528_91504679 | 0.69 |
LUM |
lumican |
1005 |
0.61 |
chr5_14268280_14268580 | 0.69 |
TRIO |
trio Rho guanine nucleotide exchange factor |
22656 |
0.28 |
chr10_4284967_4285185 | 0.69 |
ENSG00000207124 |
. |
272068 |
0.02 |
chr6_17418741_17419244 | 0.69 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
25049 |
0.25 |
chr21_30674225_30674446 | 0.69 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
1212 |
0.49 |
chr18_70210992_70211675 | 0.69 |
CBLN2 |
cerebellin 2 precursor |
441 |
0.91 |
chr4_125631421_125631706 | 0.69 |
ANKRD50 |
ankyrin repeat domain 50 |
2324 |
0.48 |
chr4_111397030_111397405 | 0.69 |
ENPEP |
glutamyl aminopeptidase (aminopeptidase A) |
12 |
0.98 |
chr5_140710087_140710515 | 0.69 |
PCDHGA1 |
protocadherin gamma subfamily A, 1 |
49 |
0.92 |
chr15_48933837_48934008 | 0.69 |
FBN1 |
fibrillin 1 |
3996 |
0.32 |
chr15_77694972_77695168 | 0.68 |
PEAK1 |
pseudopodium-enriched atypical kinase 1 |
17372 |
0.22 |
chr3_100710268_100710452 | 0.68 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
1937 |
0.43 |
chr12_91505056_91505217 | 0.68 |
LUM |
lumican |
472 |
0.85 |
chr7_143581670_143581927 | 0.68 |
FAM115A |
family with sequence similarity 115, member A |
665 |
0.7 |
chr6_19691587_19692480 | 0.68 |
ENSG00000200957 |
. |
49273 |
0.18 |
chr12_78334931_78335200 | 0.67 |
NAV3 |
neuron navigator 3 |
24991 |
0.28 |
chr9_79520083_79520617 | 0.67 |
PRUNE2 |
prune homolog 2 (Drosophila) |
651 |
0.82 |
chr15_86167313_86167464 | 0.67 |
RP11-815J21.3 |
|
3532 |
0.18 |
chr12_70649360_70649511 | 0.67 |
CNOT2 |
CCR4-NOT transcription complex, subunit 2 |
11904 |
0.22 |
chr4_114680711_114680982 | 0.67 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
1378 |
0.6 |
chr4_89978098_89978439 | 0.67 |
FAM13A |
family with sequence similarity 13, member A |
43 |
0.98 |
chr18_48571368_48571694 | 0.67 |
SMAD4 |
SMAD family member 4 |
202 |
0.96 |
chr5_14443711_14444058 | 0.67 |
TRIO |
trio Rho guanine nucleotide exchange factor |
44673 |
0.2 |
chr10_91275432_91275930 | 0.67 |
SLC16A12 |
solute carrier family 16, member 12 |
19632 |
0.18 |
chr4_134070427_134071051 | 0.67 |
PCDH10 |
protocadherin 10 |
269 |
0.96 |
chr7_116139850_116140714 | 0.67 |
CAV2 |
caveolin 2 |
448 |
0.62 |
chr4_120446718_120446900 | 0.66 |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
6555 |
0.24 |
chr16_65102470_65102680 | 0.66 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
3541 |
0.4 |
chr10_114718428_114718838 | 0.66 |
RP11-57H14.2 |
|
6999 |
0.23 |
chr11_97853691_97853842 | 0.66 |
ENSG00000216073 |
. |
69877 |
0.14 |
chr2_200844549_200844884 | 0.66 |
C2orf47 |
chromosome 2 open reading frame 47 |
24172 |
0.18 |
chr3_64172371_64172810 | 0.66 |
PRICKLE2-AS3 |
PRICKLE2 antisense RNA 3 |
630 |
0.74 |
chr18_65182595_65182802 | 0.66 |
DSEL |
dermatan sulfate epimerase-like |
1519 |
0.48 |
chr4_95375557_95376023 | 0.66 |
PDLIM5 |
PDZ and LIM domain 5 |
606 |
0.85 |
chr7_107638965_107639116 | 0.66 |
ENSG00000238297 |
. |
1387 |
0.38 |
chr12_102873850_102874216 | 0.66 |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
69 |
0.99 |
chr3_104078695_104079148 | 0.66 |
ENSG00000265076 |
. |
305281 |
0.01 |
chr1_215179577_215179737 | 0.66 |
KCNK2 |
potassium channel, subfamily K, member 2 |
459 |
0.91 |
chr21_17792662_17793003 | 0.65 |
ENSG00000207638 |
. |
118577 |
0.06 |
chr7_16025680_16025831 | 0.65 |
ISPD-AS1 |
ISPD antisense RNA 1 |
224358 |
0.02 |
chr4_160188472_160188729 | 0.65 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
287 |
0.93 |
chr2_38265076_38265999 | 0.65 |
RMDN2-AS1 |
RMDN2 antisense RNA 1 |
2053 |
0.33 |
chr1_149958312_149958498 | 0.65 |
OTUD7B |
OTU domain containing 7B |
24219 |
0.11 |
chr4_134068181_134068851 | 0.65 |
PCDH10 |
protocadherin 10 |
1954 |
0.52 |
chr12_104443157_104443419 | 0.65 |
GLT8D2 |
glycosyltransferase 8 domain containing 2 |
626 |
0.69 |
chr1_214435103_214435394 | 0.65 |
SMYD2 |
SET and MYND domain containing 2 |
19328 |
0.27 |
chr4_153273266_153273451 | 0.65 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
765 |
0.7 |
chr12_18622010_18622161 | 0.65 |
PIK3C2G |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
187107 |
0.03 |
chr21_36575591_36575742 | 0.65 |
RUNX1 |
runt-related transcription factor 1 |
154025 |
0.04 |
chr13_21388856_21389007 | 0.65 |
N6AMT2 |
N-6 adenine-specific DNA methyltransferase 2 (putative) |
40843 |
0.16 |
chr7_44922298_44922675 | 0.65 |
ENSG00000264326 |
. |
1087 |
0.34 |
chr20_46204322_46204473 | 0.64 |
ENSG00000221294 |
. |
4718 |
0.25 |
chr9_21677527_21678485 | 0.64 |
ENSG00000244230 |
. |
21307 |
0.21 |
chr7_134142830_134143848 | 0.64 |
AKR1B1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
555 |
0.83 |
chr4_82136415_82136770 | 0.64 |
PRKG2 |
protein kinase, cGMP-dependent, type II |
374 |
0.91 |
chr11_121968787_121969071 | 0.64 |
ENSG00000207971 |
. |
1623 |
0.3 |
chr1_196621837_196622284 | 0.64 |
CFH |
complement factor H |
874 |
0.67 |
chr20_14314971_14315122 | 0.64 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
3208 |
0.31 |
chr8_116670242_116670393 | 0.64 |
TRPS1 |
trichorhinophalangeal syndrome I |
3588 |
0.39 |
chr3_141295258_141295409 | 0.64 |
RASA2-IT1 |
RASA2 intronic transcript 1 (non-protein coding) |
51358 |
0.15 |
chr2_202663212_202663590 | 0.64 |
CDK15 |
cyclin-dependent kinase 15 |
7697 |
0.16 |
chr8_49831086_49831370 | 0.64 |
SNAI2 |
snail family zinc finger 2 |
2760 |
0.41 |
chr1_243415347_243415602 | 0.64 |
CEP170 |
centrosomal protein 170kDa |
1148 |
0.47 |
chr3_192126971_192127690 | 0.63 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr5_121407484_121407781 | 0.63 |
LOX |
lysyl oxidase |
6348 |
0.25 |
chr8_13264298_13264481 | 0.63 |
RP11-10C8.2 |
|
68306 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.6 | 2.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.6 | 1.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 1.8 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.6 | 2.3 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 1.7 | GO:0031223 | auditory behavior(GO:0031223) |
0.6 | 1.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 1.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.5 | 0.9 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.5 | 1.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 1.4 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 0.9 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 1.2 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.4 | 0.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.4 | 1.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 1.2 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.4 | 8.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 1.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 1.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 1.4 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.4 | 3.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.4 | 1.1 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.3 | 1.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 1.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.6 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 0.6 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.3 | 0.9 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.3 | 0.9 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.3 | 0.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 2.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 0.7 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.4 | GO:0003308 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.2 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 1.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 0.4 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 0.6 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 1.0 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.2 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.6 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.4 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.2 | 0.4 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.2 | 0.2 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.2 | 0.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 1.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.6 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.2 | GO:0061364 | regulation of negative chemotaxis(GO:0050923) apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 0.9 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 0.6 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.2 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 0.6 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 2.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.5 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.2 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 1.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.7 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.2 | 1.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.5 | GO:0008049 | male courtship behavior(GO:0008049) |
0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.2 | 0.2 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.2 | 0.2 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.2 | 0.2 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.2 | 0.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 3.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.9 | GO:0010092 | organ induction(GO:0001759) specification of organ identity(GO:0010092) |
0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.9 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 1.3 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0048641 | regulation of skeletal muscle tissue development(GO:0048641) |
0.1 | 2.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.4 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 1.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 1.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 2.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 1.0 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.1 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.1 | GO:0060439 | trachea morphogenesis(GO:0060439) |
0.1 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.6 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 2.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 1.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.5 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 0.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.7 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.1 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 1.4 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.6 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.2 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 3.5 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 0.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.7 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 1.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 1.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.5 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.2 | GO:0060033 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.1 | 0.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.7 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 1.4 | GO:0014033 | neural crest cell differentiation(GO:0014033) |
0.1 | 0.4 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.6 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.3 | GO:0022405 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.1 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 8.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.8 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.5 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.3 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.7 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:1903504 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.1 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.6 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.0 | 0.0 | GO:0003160 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.0 | 0.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0072087 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) renal vesicle morphogenesis(GO:0072077) renal vesicle development(GO:0072087) metanephric renal vesicle morphogenesis(GO:0072283) |
0.0 | 0.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.3 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.4 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.1 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.0 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.2 | GO:0071451 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.4 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.0 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.3 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.2 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.0 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.1 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0019226 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.0 | 0.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.0 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.2 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.1 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.2 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.2 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 2.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0032616 | interleukin-13 production(GO:0032616) regulation of interleukin-13 production(GO:0032656) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.4 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.3 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 2.1 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.0 | 0.1 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 1.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.0 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 2.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 6.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 2.4 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 3.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 2.7 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.4 | 0.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 1.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.6 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.9 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 1.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0044216 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.4 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.0 | GO:0043034 | costamere(GO:0043034) |
0.1 | 4.6 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 16.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.9 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 2.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 3.8 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 5.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 4.8 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 2.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.3 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 1.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 3.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.5 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 3.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.0 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.9 | 2.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 1.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 3.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.5 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 2.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 9.0 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 2.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 2.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.7 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.2 | 0.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 0.9 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 1.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.8 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 1.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 1.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 1.4 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 2.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 6.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.4 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 1.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.5 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.5 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.7 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.6 | GO:0034739 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 2.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.2 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 2.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 6.3 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 1.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.0 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.0 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 1.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 9.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 2.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 4.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 6.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 11.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 1.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 2.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 9.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 6.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 3.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 2.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.2 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.2 | 2.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 3.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 10.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 3.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 2.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 1.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.6 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.5 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 2.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |